241 related articles for article (PubMed ID: 29318966)
1. Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime?
Hansen PR
Curr Pharm Des; 2018; 24(3):281-290. PubMed ID: 29318966
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases.
Damen MSMA; Popa CD; Netea MG; Dinarello CA; Joosten LAB
Atherosclerosis; 2017 Sep; 264():83-91. PubMed ID: 28716457
[TBL] [Abstract][Full Text] [Related]
4. Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.
Moss JW; Ramji DP
Future Med Chem; 2016 Jul; 8(11):1317-30. PubMed ID: 27357616
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors in inflammatory arthritis.
Mirjafari H; Al-Husain A; Bruce IN
Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670
[TBL] [Abstract][Full Text] [Related]
6. Current Therapeutic Approaches for Targeting Inflammation in Depression and Cardiovascular Disease.
Zuzarte P; Duong A; Figueira ML; Costa-Vitali A; Scola G
Curr Drug Metab; 2018; 19(8):674-687. PubMed ID: 29512447
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory therapy in atherosclerosis.
Kocyigit D; Gurses KM; Tokgozoglu L
Front Biosci (Landmark Ed); 2020 Jan; 25(2):242-269. PubMed ID: 31585888
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular co-morbidity in rheumatic diseases.
Turesson C; Jacobsson LT; Matteson EL
Vasc Health Risk Manag; 2008; 4(3):605-14. PubMed ID: 18827910
[TBL] [Abstract][Full Text] [Related]
9. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
Nordestgaard BG; Zacho J
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
[TBL] [Abstract][Full Text] [Related]
10. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms.
Martínez-Hervás S; González-Navarro H
Rev Esp Cardiol (Engl Ed); 2019 Sep; 72(9):767-773. PubMed ID: 31155366
[TBL] [Abstract][Full Text] [Related]
12. Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Shen J; Shang Q; Tam LS
Transl Res; 2016 Jan; 167(1):138-51. PubMed ID: 26051628
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease in rheumatoid arthritis.
Kaplan MJ
Curr Opin Rheumatol; 2006 May; 18(3):289-97. PubMed ID: 16582694
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease management through restrained inflammatory responses.
Jabir NR; Tabrez S
Curr Pharm Des; 2016; 22(7):940-6. PubMed ID: 26648461
[TBL] [Abstract][Full Text] [Related]
15. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.
Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM
Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657
[TBL] [Abstract][Full Text] [Related]
16. Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
Muhammad K; Ayoub MA; Iratni R
Curr Pharm Des; 2021; 27(18):2141-2150. PubMed ID: 33461451
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Diseases and Periodontitis.
Hansen PR; Holmstrup P
Adv Exp Med Biol; 2022; 1373():261-280. PubMed ID: 35612803
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory drugs and atherosclerosis.
Moubayed SP; Heinonen TM; Tardif JC
Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
[TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic Disorders in Psoriatic Disease.
Sobchak C; Eder L
Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives.
Patoulias D; Stavropoulos K; Imprialos K; Athyros V; Grassos H; Doumas M; Faselis C
Curr Vasc Pharmacol; 2021; 19(3):323-342. PubMed ID: 32188386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
